Ben Garmezy, MD

home / authors / ben-garmezy-md

Articles

Episode 3: Traversing the Complexities of Non-Clear Cell Renal Cell Carcinoma

Manojkumar Bupathi, MD, MS;Ben Garmezy, MD;Stephanie A. Berg, DO

March 7th 2025

A brief overview of the current RCC landscape was provided in the most recent Oncology Decoded podcast.

Episode 2: Navigating Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer

Manojkumar Bupathi, MD, MS;Ben Garmezy, MD;David Morris, MD, MS;Tanya B. Dorff, MD;Mark T. Fleming, MD

March 5th 2025

A patient case of a 50-year-old man with hormone-sensitive prostate cancer sparked a debate among oncologists regarding the best course of action.

Episode 1: NIAGARA Study is the Forefront of Post-ASCO GU Discussion in Bladder Cancer

Manojkumar Bupathi, MD, MS;Ben Garmezy, MD;Petros Grivas, MD, PhD;David Morris, MD, MS

March 4th 2025

The Oncology Decoded podcast highlighted the impact of the results from the NIAGARA trial for patients with bladder cancer in a post-ASCO GU discussion.

Oncology Decoded: Genitourinary Cancer Therapies – Teaser

Manojkumar Bupathi, MD, MS;Ben Garmezy, MD

February 7th 2025

Manojkumar Bupathi, MD, MS, and Ben Garmezy, MD, discuss how to optimize treatment approaches for genitourinary cancers through evaluation of real-world data, sequencing strategies, and toxicity management while working to bridge care disparities between community and academic settings.